Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT02227199 · COMPLETED
Trial details
- NCT number
- NCT02227199
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-10
- Primary completion
- 2020-03-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.